Adults with erectile dysfunction may be prescribed Viagra to support erections during sexual stimulation. Viagra contains sildenafil, a PDE5 inhibitor that increases penile blood flow. It is taken orally as a tablet when needed.
Viagra contains sildenafil citrate, the active pharmaceutical ingredient responsible for its effect. Sildenafil belongs to the phosphodiesterase type 5 inhibitor class and is used for erectile dysfunction in adult men.
Viagra was developed by Pfizer and has been assessed by regulators including Medsafe and the European Medicines Agency.
Viagra does not create sexual desire and does not produce an erection without arousal. It also does not protect against sexually transmitted infections or act as contraception.
The distinction between sexual stimulation and automatic erection is useful. Sildenafil supports the body’s normal erectile pathway; it does not work as an aphrodisiac.
The appropriate sildenafil dose differs between strengths and between users, so there is no single amount that suits everyone. Clinicians generally select the lowest dose that provides a satisfactory response with acceptable tolerability. Viagra is taken by mouth when needed before anticipated sexual activity.
The maximum recommended frequency is one dose in 24 hours. A higher dose is not automatically better than a lower dose; it may produce more adverse effects without improving the erection. The product information reviewed by Medsafe describes dose adjustment according to efficacy and tolerability [2].
Older adults and people with significant kidney or liver impairment may require a lower starting dose. Strong CYP3A4 inhibitors can also increase sildenafil exposure. These decisions belong in the prescribing assessment rather than being made by trial and error.
Sexual stimulation causes the release of nitric oxide in penile tissue. This increases cyclic guanosine monophosphate, or cGMP, which relaxes smooth muscle and allows blood to enter the erectile tissue. PDE5 normally breaks down cGMP. Sildenafil inhibits PDE5, helping cGMP remain active for longer and supporting an erection when sexual stimulation is present [1].
Sildenafil belongs to the phosphodiesterase type 5 inhibitor class and is used for erectile dysfunction in adult men.
Viagra is one PDE5 inhibitor used for erectile dysfunction. Tadalafil is another medicine in the same class, marketed under names including Cialis. Their mechanisms overlap, but their pharmacokinetic profiles differ.
| Medicine | Active ingredient | Usual clinical profile |
|---|---|---|
| Viagra | Sildenafil | Often taken before planned sexual activity; onset commonly occurs within about 30–60 minutes |
| Tadalafil | Tadalafil | Often has a longer window of effect; onset may occur from about 30 minutes |
| PDE5 inhibitor class | Varies by medicine | Supports erection only when sexual stimulation activates the erectile pathway |
Sildenafil is often selected when a person prefers planned, occasion-based dosing. Tadalafil may suit people who prefer a longer period in which sexual activity can occur, though its longer exposure also means adverse effects may persist for longer. The choice depends on cardiovascular status, other medicines, kidney and liver function, previous response and personal timing preferences.
A longer duration does not mean a continuous erection. A persistent erection lasting four hours or more is an emergency, regardless of which PDE5 inhibitor was taken.
Viagra is not for you if you use nitrates, have been advised to avoid sexual activity, or have a serious allergy to sildenafil. It should not be used by a person taking nitrates or nitric-oxide donor medicines for angina. It is also unsuitable for anyone with a previous serious allergic reaction to sildenafil or an excipient in the tablet.
Viagra is intended for adult men with erectile dysfunction, not for women or children.
The available product information does not provide a specific list of sildenafil adverse effects or interactions. If symptoms occur after taking Viagra, contact a clinician for advice. Seek urgent medical care for severe or rapidly worsening symptoms.
Several practical errors can reduce the apparent benefit of Viagra or increase risk:
One easily missed detail is the 24-hour limit. The medicine’s effect may decline before 24 hours has passed, but that does not make another dose appropriate. Sildenafil exposure can remain clinically relevant even when the subjective effect has faded.
Another mistake is judging the medicine only by erection firmness. Duration, ability to maintain the erection, adverse effects and recovery after orgasm also matter when treatment is reviewed.
Doctors generally set expectations before treatment begins. Sildenafil improves the physical response to stimulation; it does not resolve relationship distress, severe performance anxiety, low libido or untreated endocrine disease by itself.
A prescriber usually considers three practical questions:
Clinicians also look for changes in cardiovascular health. Erectile dysfunction and coronary artery disease share vascular risk factors, so new or worsening symptoms can justify blood-pressure testing, glucose assessment and cardiovascular review.
Patients often report that the first dose was taken too soon after a large meal or after drinking heavily. A more useful assessment uses several appropriately timed attempts, provided the medicine is being used within the prescribed limits. The European Medicines Agency’s Viagra assessment describes sildenafil as a treatment for erectile dysfunction that requires sexual stimulation for its effect [3].
Sildenafil commonly begins working within about 30–60 minutes when sexual stimulation is present. The useful erectile response often lasts for several hours, though it does not cause a continuous erection. FDA prescribing information available in 2024 describes sildenafil as an as-needed treatment whose effect depends on sexual stimulation and individual pharmacokinetics.
Do not take another tablet on the same day if the first attempt does not produce the desired response. Medsafe information available in 2022 supports reviewing timing, food, alcohol, sexual stimulation, interacting medicines and dose tolerability before changing treatment. Persistent lack of benefit should lead to a prescriber-led assessment for cardiovascular, hormonal, medication-related or psychological contributors.
Alcohol can worsen dizziness, flushing and low blood pressure, while heavy drinking can reduce erectile performance. The World Health Organization’s sexual-health materials available in 2023 support addressing alcohol and vascular risk factors when erectile symptoms are assessed. Avoid heavy alcohol intake around dosing, and do not use alcohol to compensate for an inadequate response.
Sildenafil can cause dizziness or visual changes in some people, which may impair driving, concentration or machinery work. The FDA label available in 2024 advises attention to individual response before undertaking activities requiring clear vision and alertness. Do not drive or operate machinery if dizziness, blurred vision or altered colour perception occurs.
Sildenafil does not usually require tapering because it is used intermittently and does not create physical dependence. The European Medicines Agency’s Viagra assessment from 2018 describes treatment as use when needed rather than a withdrawal-producing course. Erectile difficulties may return after stopping because the underlying condition remains, but stopping does not cause a rebound requirement for higher doses.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Whanganui, used the prescribed 50 mg dose for several weeks: “The first attempt was disappointing because I had taken it after a big dinner. On later occasions, with a lighter meal and more time before sex, the response was much better. I noticed flushing, but it passed.”
Dunedin, used sildenafil on planned occasions: “It helped with maintaining an erection, although the headache was noticeable twice. I stopped drinking before taking it and that seemed to make the evening more predictable. I did not increase the dose when one attempt went poorly.”
Wellington, tried treatment for situational erectile difficulty: “The physical effect was present, but anxiety still got in the way at first. I also felt a blocked nose and mild colour change in my vision. A later medical review helped me understand that the tablet was not intended to create arousal.”
Hamilton, used sildenafil after cardiovascular screening: “The treatment worked adequately, but the facial flushing and indigestion made the higher dose unpleasant. A lower dose was more comfortable. I kept the tablets at home and took them only as prescribed.”
